Related Articles
Analysis of the selection of CDK4/6 inhibitors based on experience using palbociclib
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles
CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomas
MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma